{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:53:55Z","timestamp":1770969235106,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":4419,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.ymthe.2004.05.014","type":"journal-article","created":{"date-parts":[[2004,7,21]],"date-time":"2004-07-21T18:25:30Z","timestamp":1090434330000},"page":"456-468","source":"Crossref","is-referenced-by-count":17,"title":["In Vivo Selection of Genetically Modified Erythroid Cells Using a Jak2-Based Cell Growth Switch"],"prefix":"10.1016","volume":"10","author":[{"given":"Shengming","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Weinreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.Anthony","family":"Blau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2004.05.014_BIB1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.7694365","article-title":"Controlling signal transduction with synthetic ligands","volume":"262","author":"Spencer","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB2","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood.V97.9.2535","article-title":"Pharmacologically regulated cell therapy","volume":"97","author":"Neff","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB3","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1073\/pnas.94.7.3076","article-title":"A proliferation switch for genetically modified cells","volume":"94","author":"Blau","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB4","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1182\/blood.V90.10.3884","article-title":"Development of a novel selective amplifier gene for controllable expansion of transduced hematopoietic cells","volume":"90","author":"Ito","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB5","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1182\/blood.V91.3.890","article-title":"Stimulating cell proliferation through the pharmacologic activation of c-kit","volume":"91","author":"Jin","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB6","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1073\/pnas.95.14.8093","article-title":"Targeted expansion of genetically modified bone marrow cells","volume":"95","author":"Jin","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB7","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1521-2254(199907\/08)1:4<236::AID-JGM42>3.0.CO;2-2","article-title":"A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells","author":"Xu","year":"1999","journal-title":"J. Gene Med"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood.V98.2.328","article-title":"Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cells","volume":"98","author":"Zeng","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1182\/blood.V95.2.430","article-title":"Expansion of genetically modified primary human hemopoietic cells using chemical inducers of dimerization","volume":"95","author":"Richard","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1634\/stemcells.21-1-71","article-title":"Selective expansion of genetically modified cord blood cells","volume":"21","author":"Richard","year":"2003","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/79194","article-title":"In vivo selection using a cell growth switch","volume":"26","author":"Jin","year":"2000","journal-title":"Nat. Genet"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB12","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2003-10-3705","article-title":"Modulating erythrocyte mixed chimerism in a mouse model of pyruvate kinase deficiency","author":"Richard","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB13","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1182\/blood-2002-03-0792","article-title":"Pharmacologically regulated in vivo selection in a large animal","volume":"100","author":"Neff","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0092-8674(93)90414-L","article-title":"JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin","volume":"74","author":"Witthuhn","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB15","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1074\/jbc.270.10.4979","article-title":"The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl","volume":"270","author":"Drachman","year":"1995","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood.V86.1.23.bloodjournal86123","article-title":"Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets","volume":"86","author":"Miyakawa","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB17","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1182\/blood.V85.12.3444.bloodjournal85123444","article-title":"Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2","volume":"85","author":"Tortolani","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB18","first-page":"1040","article-title":"The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases","volume":"23","author":"Sattler","year":"1995","journal-title":"Exp. Hematol"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB19","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1073\/pnas.90.18.8429","article-title":"Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction","volume":"90","author":"Silvennoinen","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB20","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1128\/MCB.14.7.4335","article-title":"JAK2 associates with the beta c chain of the receptor for granulocyte\u2013macrophage colony-stimulating factor, and its activation requires the membrane-proximal region","volume":"14","author":"Quelle","year":"1994","journal-title":"Mol. Cell Biol"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB21","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1084\/jem.180.6.2101","article-title":"IL-5 receptor-mediated tyrosine phosphorylation of SH2\/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases","volume":"180","author":"Sato","year":"1994","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB22","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1073\/pnas.91.12.5232","article-title":"Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants","volume":"91","author":"Campbell","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0092-8674(93)90415-M","article-title":"Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase","volume":"74","author":"Argetsinger","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(00)81167-8","article-title":"Jak2 is essential for signaling through a variety of cytokine receptors","volume":"93","author":"Parganas","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0092-8674(00)81168-X","article-title":"Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis","volume":"93","author":"Neubauer","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB26","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood.V98.7.2077","article-title":"Membrane localization is not required for Mpl function in normal hematopoietic cells","volume":"98","author":"Otto","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB27","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/emboj\/21.9.2159","article-title":"JAK2, complemented by a second signal from c-kit or flt-3, triggers extensive self-renewal of primary multipotential hemopoietic cells","volume":"21","author":"Zhao","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/13657","article-title":"Fluorescent proteins from nonbioluminescent Anthozoa species","volume":"17","author":"Matz","year":"1999","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB29","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(05)60614-9","article-title":"Granulocytosis causing sickle-cell crisis","volume":"351","author":"Abboud","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB30","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1182\/blood.V97.10.3313","article-title":"Fatal sickle cell crisis after granulocyte colony-stimulating factor administration","volume":"97","author":"Adler","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB31","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1182\/blood.V97.12.3998","article-title":"Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell\/beta+ thalassemia","volume":"97","author":"Wei","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/blood-2002-07-2131","article-title":"Gene therapy of apolipoprotein E-deficient mice using a novel macrophage-specific retroviral vector","volume":"101","author":"Gough","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB33","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1182\/blood.V98.9.2664","article-title":"High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors","volume":"98","author":"Moreau-Gaudry","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB34","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1093\/emboj\/17.18.5321","article-title":"Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL\/JAK2 fusion genes","volume":"18","author":"Schwaller","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1097-2765(00)00067-8","article-title":"Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL\/JAK2","volume":"6","author":"Schwaller","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0952-7915(02)00323-0","article-title":"New perspectives on a developmental dilemma: the kinetic signaling model and the importance of signal duration for the CD4\/CD8 lineage decision","volume":"14","author":"Singer","year":"2002","journal-title":"Curr. Opin. Immunol"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB37","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1126\/science.1071551","article-title":"Control of T cell function by positive and negative regulators","volume":"296","author":"Singer","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB38","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.1074\/jbc.M010074200","article-title":"The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2","volume":"276","author":"Kamizono","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB39","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1128\/MCB.21.10.3547-3557.2001","article-title":"Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation","volume":"21","author":"Frantsve","year":"2001","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB40","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1128\/MCB.17.9.4991","article-title":"Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway","volume":"17","author":"Rouyez","year":"1997","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB41","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1182\/blood.V94.4.1273","article-title":"Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis","volume":"94","author":"Rojnuckarin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.05.014_BIB42","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood.V97.5.1249","article-title":"A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease","volume":"97","author":"Thomis","year":"2001","journal-title":"Blood"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604001790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604001790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T20:26:08Z","timestamp":1585859168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001604001790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1525001604001790"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2004.05.014","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}